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Mouse lymphoma cells contain a nonactivated glucocorticoid receptor of Mr ~ 330000 which is heteromeric n nature 
and is unable to bind to DNA. Following affinity labeling of the steroid-binding subunit and subsequent cross-linking 
with dimethyl suberimidate atvarious times either in cell extracts or in intact cells, a series of labeled bands was detected 
in SDS gels. From the molecular masses of completely and partially cross-linked complexes we conclude that the large 
nonactivated receptor is a tetramer composed of two 90 kDa subunits, one 50 kDa polypeptide and one steroid-binding 
subunit. 
Chemical crosslinking; Dexamethasone m sylate; Dimethyl suberimidate; Glucocorticoid receptor; Subunit structure 
1. INTRODUCTION 
The physiological effects of steroid hormones 
are mediated by intracellutar receptors which may 
exist in different molecular forms in extracts of 
target cells (reviews [1,2]). During recent years it 
became clear that high molecular mass glucocor- 
ticoid receptors are unable to interact with DNA or 
chromatin but become activated to a DNA-binding 
state upon warming or exposure to high ionic 
strength: this process involves subunit dissociation 
[3-6]. The large receptor form of Mr -330000 has 
recently been shown by chemical cross-linking to 
exist not only in cell extracts but also in intact cells 
[6]. It contains only one hormone-binding 
potypeptide of Mr - I00000 per complex [7,8]. We 
now know that the heat shock protein hsp90 is a 
constituent of the heteromeric gtucocorticoid 
receptor structure [4,6,9,10]: it may be present as 
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a dimer [5,11,12]. The involvement of other 
molecular components i less clear. A polypeptide 
of  Mr  59000 was  detected in association with 
several steroid hormone receptors [13]. RNA has 
also been envisaged as part of large glucocorticoid 
receptors (review [14]). In the present study we in- 
vestigated high molecular mass glucocorticoid 
receptors in terms of numbers of macromolecular 
subunits and used cross-linking with a bifunctionaI 
reagent that allows subsequent analysis in SDS 
gels. The detection of several intermediate forms 
provides compelling evidence for the high 
molecular mass receptor being a hetero-tetramer. 
2. MATERIALS AND METHODS 
2.1. Cell culture and cell extracts 
The $49.1 mouse lymphoma sublines $49.tG.3 (wild-type) 
and S49.1TB.4.143R (nti mutant) were those previously used 
[15]. Cells were grown and harvested as described [5] and cell 
pellets were stored frozen. Extracts were prepared from frozen 
cells [6] and were incubated with 100 nM [3Hldexamethasone 
mesylate (NEN Research Products; 1.8 TBq/mmol) for 2.5 h at 
0°C. Extracts of wild-type cells were then used for cross-linking 
while those of nt i cells were first submitted to gel filtration on 
Sephacryl S-300 in a buffer containing 20 mM sodium molyb- 
date and 150 mM KC1 [5]. Peak fractions corresponding to 
70 A Stokes radius were combined and submitted to cross- 
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linking. Intact cells were incubated with labeled hormone as 
previously described [6] except that dexamethasone mesylate 
was used, extracts were prepared subsequently to cross-linking 
and extensive washing of cells. 
2.2. Chemical cross-linking 
Cross-linking with DMS (Pierce Chemical Co.) was carried 
out according to a protocol described by Ar~myi et al. [16]. 
Reactions were at 6-8°C for the times given. Intact cells were 
treated in the same way except hat cell suspensions were ad- 
justed to pH 8.0 by KOH. Wild-type receptors were subsequent- 
ly purified on Sepharose to which the receptor specific antibody 
mab 49 had been coupled [6]. The eluate with sodium thio- 
cyanate was precipitated with trichloroacetic a id and prepared 
for SDS-PAGE [6]. Cross-linked nti-receptor fractions were 
passed over Sephadex G-25 in order to remove xcess reagent as 
well as molybdate prior to precipitation with trichloroacetic 
acid. 
2.3. SDS-PAGE 
We used polyacrylamide slab gels (1.5 mm thickness) in a 
continuous buffer system [17]. Gels were prepared from 3.307o 
acrylamide and 0.1107o methylenebisacrylamide n buffer 
(50 mM Tris phosphate, pH 7.2, 0.1070 SDS) and run at a con- 
stant voltage of 100 V. Samples of 40/~1 were applied to slots 
of 1.5 cm. As markers we used rabbit muscle phosphorylase a 
(subunit Mr 97400) which had been incompletely cross-linked 
with DMS. Gels were stained with Coomassie and dried onto 
filter paper. Routinely, slices of 2 mm were taken, dissolved in 
3007o H202, and radioactivity measured by liquid scintillation 
counting; in some experiments he gels were cut in slices of 
about 600/tm. 
3. RESULTS 
3.1. Cross-linking in extracts of  wild-type cells 
The hormone-b ind ing  po lypept ide  o f  large 
receptor  complexes  was labe led  cova lent ly  w i th  the 
s tero id  [3H]dexamethasone  mesy la te  wh ich  is 
known to  a f f in i ty  label  g lucocor t i co id  receptors  
w i th  h igh  yield [18]. S ince,  however ,  o ther  ce l lu lar  
mater ia l  is non-spec i f i ca l ly  labe led  w i th  th is  
reagent  [19], a receptor  speci f ic  pur i f i ca t ion  pro-  
cedure  was necessary .  For  the  w i ld - type  receptor  
we used  immunoaf f in i ty  chromatography  w i th  the  
monoc lona l  ant ibody  mab 49 wh ich  recogn izes  a 
domain  o f  the  s tero id -b ind ing  po lypept ide  that  
Fig.1. SDS-PAGE of wild-type receptors cross-linked in cell 
extracts. Cross-linking was for 0 (A), 20 (B), 40 (C) and 60 (D) 
rain. Gels were run for 3.5 h. Multimers of the phosphorylase 
a subunit are indicated by arrows (1-4). 
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does not participate in cross-linking [6] and is miss- 
ing from the nt' mutant receptor [20]. Fig.1 shows 
a series of SDS gels in which wild-type receptors 
were cross-linked with DMS for various lengths of 
time. Starting out with a single labeled peak of Mr 
-100000 (fig.lA) increasingly complex patterns 
were obtained which finally shifted towards a ma- 
jor species of Mr ~350000 (fig.lD). This cor- 
responds to the fully cross-linked receptor 
previously obtained with other methods [6]. A 
total of 6 peaks was observed (table 1). Even 
though forms b and e were less prominent than the 
other intermediate species c and d they were con- 
sistently seen: they became particularly obvious 
when gels were cut into 600/~m slices (not shown). 
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Fig.3. SDS-PAGE of wild-type receptors cross-linked in intact 
cells. Cross-linking was for 30 (A) and 90 (B) min; other details 
as in fig.1. 
Fig.2. SDS-PAGE of nt i receptors cross-linked in cell extracts. 
Symbols as in fig.1. Gels were run for 2.5 h. 
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Table 1 
Cross-linking of receptors 
December 1988 
Receptor type Molecular masses of labeled receptor species 
a b c d e f 
Wild-type 104000 _+ 5000 149000 +5000 194000 ___ 10000 241000 +_ 9000 301000 +_ 12000 349000 +_ 8000 
(11) (4) (9) (6) (5) (6) 
nt i mutant 51000 +_ 4000 95000 _+ 4000 136000 _+ 7000 178000 _+ 7000 214000 +_ 6000 264000 _+ 10000 
(8) (5) (8) (7) (2) (7) 
Molecular masses were determined in SDS gels. Mean values and ranges are reported (number of experiments in parentheses) 
3.2. Cross-linking in extracts of  nt i mutant cells 
In order to conf irm the above data we carried 
out similar experiments with the nt i receptor which 
has a glucocorticoid-binding polypeptide of about 
half the wild-type size [15] and a high molecular 
mass form of about 290 kDa [5-7]. This receptor 
form was separated from nonspecifically labeled 
material by gel f i ltration in the presence of molyb- 
date [5]. As shown in fig.2 we again observed a 
series of 6 labeled receptor species. The Mr data are 
summarized in table 1. 
3.3. Receptor cross-linking in intact cells 
In other experiments we incubated wild-type 
cells in the cold with the aff inity label and subse- 
quently with DMS. Cells were broken and recep- 
tors were immunoaf f in i ty  purified and subjected 
to SDS-PAGE.  Fig.3 shows that cross-linking is 
less efficient than in cell extracts, however, the 
same labeled receptor species were observed. 
4. DISCUSSION 
In previous experiments we achieved chemical 
cross-l inking between receptor subunits by using 
Table 
bi funct ional  N-hydroxysuccinimide esters [6]. 
These compounds,  however, give rise to covalent 
links which are unstable under the condit ions com- 
monly used for SDS-PAGE.  We therefore now 
turned to bis-imidates like DMS which produce 
more stable amidine cross-links. With both wild- 
type and nt ~ receptors we obtained in SDS gels sets 
of 6 labeled receptor species with varying yields 
depending largely on the extent of cross-linking. 
The molecular mass data, compiled in table 1, 
strongly suggest a tetrameric structure for the high 
molecular mass forms of both receptor types. 
Table 2 presents our interpretation f the data. We 
conclude that the large receptors contain two 
subunits of Mr 90000 and one polypeptide of Mr 
-50000 in association with one steroid-binding 
subunit  of either Mr -100000 (wild-type) or 50000 
(nti). 
As to the identity of the 90 kDa subunits it is 
clear that hsp90 is at least one of these com- 
ponents. In fact, Mendel and Orti [12] recently 
provided evidence for a roughly 1:2 ratio of 
steroid-binding subunit o hsp90. In contrast, the 
identity of the subunit  of Mr -50000 is still 
unknown.  Since the cross-linker DMS has a high 
Interpretation of Mr data 
Wild-type nt ~ mutant type 
a Mr -105000: R 
b Mr -150000: R + p50 
c Mr -195000: R + p90 
d Mr -240000: R + p90 + p50 
e Mr -300000: R + p90 + p90 
f Mr -350000: R + p90 + p90 + p50 
MF --50000: R 
Mr ~95000: R + p50 
Mr ~135000: R + p90 
Mr -180000: R + p90 + p50 
Mr -215000: R + p90 + p90 
Mr -265000: R + p90 + p90 + p50 
R refers to the steroid-binding polypeptides of Mr -100000 (wild-type) and 50000 
(nti); p90 and pS0 refer to associated polypeptides of Mr 90000 and 50000, 
respectively. The letters a to f relate to the labeled peaks in figs 1-3 
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degree of selectivity for amino groups in proteins 
[21] we assume that all four receptor subunits are 
of polypeptide nature. 
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